Role of the addition of cabergoline to the management of acromegalic patients resistant to longterm treatment with octreotide LAR
✍ Scribed by Lucio Vilar; Monalisa F. Azevedo; Luciana Ansaneli Naves; Luiz Augusto Casulari; José Luciano Albuquerque; Renan M. Montenegro; Renan M. Montenegro; Patricia Figueiredo; Gilvan C. Nascimento; Manuel S. Faria
- Book ID
- 106497441
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 274 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1386-341X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Patients with advanced prostate carcinoma that had been stabilized by orchiectomy (ORCH) or hormone therapy for at least 3 months, were randomized to either diethylstilbestrol (DES) alone or DES plus Cytoxan or DES plus Emcyt. A total of 188 patients were randomized between July, 1976 a
## Abstract We report the first large‐scale double‐blind, randomly assigned study to compare two active dopaminergic therapies for Restless Legs Syndrome (RLS), the dopamine agonist cabergoline (CAB) and levodopa/benserazide (levodopa). Patients with idiopathic RLS were treated with fixed daily dos